lung cancer

You have access
Erlotinib Activates Different Cell Death Pathways in EGFR-mutant Lung Cancer Cells Grown in 3D Versus 2D Culture Systems
HYUN-KYUNG LEE, MIN HYE NOH, SEUNG-WOO HONG, SEUNG-MI KIM, SUNG HYUN KIM, YEONG SEOK KIM, V. COURTNEY BROADDUS and DAE YOUNG HUR

Anticancer Research March 2021, 41 (3) 1261-1269; DOI: https://doi.org/10.21873/anticanres.14883
You have access
Autoantibody Positivity Is a Risk Factor for Chemotherapy-induced Exacerbation of Interstitial Pneumonia in Lung Cancer
NORIAKI ITO, TAKESHI MASUDA, TAKU NAKASHIMA, SATOSHI NAKAO, KAKUHIRO YAMAGUCHI, SHINJIRO SAKAMOTO, YASUSHI HORIMASU, SHINTARO MIYAMOTO, HIROSHI IWAMOTO, KAZUNORI FUJITAKA, HIRONOBU HAMADA and NOBORU HATTORI

Anticancer Research March 2021, 41 (3) 1497-1506; DOI: https://doi.org/10.21873/anticanres.14908
You have access
Extracellular Water-to-total Body Water Ratio as an Objective Biomarker for Frailty in Lung Cancer Patients
TOMONORI HIRASHIMA, YOSHIMI NODA, HIDEKAZU SUZUKI, SHINGO NASU, AYAKO TANAKA, NAOKO MORISHITA, NORIKO RYOTA, KAORI IWATA, YUKARI OKADA and NORIO OKAMOTO

Anticancer Research March 2021, 41 (3) 1655-1662; DOI: https://doi.org/10.21873/anticanres.14928
You have access
Drug-induced Interstitial Lung Disease Has the Same Degree of Risk for Mortality as Old Age in Patients With Lung Cancer
KOHEI IWASHITA, TOMOHIRO MIZUNO, SATOMI KUMAZAWA, KAZUYOSHI IMAIZUMI and SHIGEKI YAMADA

Anticancer Research March 2021, 41 (3) 1707-1711; DOI: https://doi.org/10.21873/anticanres.14935
You have access
Reversion from Methionine Addiction to Methionine Independence Results in Loss of Tumorigenic Potential of Highly-malignant Lung-cancer Cells
JUN YAMAMOTO, YUSUKE AOKI, QINGHONG HAN, NORIHIKO SUGISAWA, YU SUN, KAZUYUKI HAMADA, HIROTO NISHINO, SACHIKO INUBUSHI, KENTARO MIYAKE, RYUSEI MATSUYAMA, MICHAEL BOUVET, ITARU ENDO and ROBERT M. HOFFMAN

Anticancer Research February 2021, 41 (2) 641-643; DOI: https://doi.org/10.21873/anticanres.14815
You have access
Newly Synthesized DNA Methyltransferase Inhibitors as Radiosensitizers for Human Lung Cancer and Glioblastoma Cells
CHAN WOO WEE, JIN HO KIM, HAK JAE KIM, HYUN-CHEOL KANG, SOO YOUN SUH, BEOM SOO SHIN, EUNSOOK MA and IL HAN KIM

Anticancer Research February 2021, 41 (2) 757-764; DOI: https://doi.org/10.21873/anticanres.14827
You have access
ADGRF4 Regulates Non-small Cell Lung Cancer Cell Invasiveness
JI-HYE YOON and SUNG-GOOK CHO

Anticancer Research December 2020, 40 (12) 6835-6844; DOI: https://doi.org/10.21873/anticanres.14705
You have access
Outcomes and Prognostic Factors Following Surgical Treatment of Pulmonary Metastases from Colorectal Carcinoma
JOSEF VODIČKA, JAKUB FICHTL, JAKUB ŠEBEK, KRISTÝNA PROCHÁZKOVÁ, MARTIN SKÁLA, VLADISLAV TŘEŠKA, STANISLAV KORMUNDA, BOHUSLAVA VAŇKOVÁ, MARTIN SVATOŇ, ONDŘEJ TOPOLČAN and RADEK KUČERA

Anticancer Research December 2020, 40 (12) 7045-7051; DOI: https://doi.org/10.21873/anticanres.14731
You have access
Factors Influencing Social Isolation and Loneliness Among Lung Cancer Patients: A Cross-sectional Study
NANAMI ASHI, YUKI KATAOKA, TOMOYASU TAKEMURA, CHIGUSA SHIRAKAWA, KOYA OKAZAKI, AZUSA SAKURAI, TAKUMA IMAKITA, SHUNKICHI IKEGAKI, HIROTAKA MATSUMOTO, EMIKO SAITO, HIROHITO TAKATA, SAWAKO KAKU, NOBUKO WADA, MARIKO SHINOMIYA, TAKEHIRO OTOSHI, MASATOSHI SHIMADA, JUNICHI NIKAIDO, REIKA IKI, KATSUYA HIRANO, TOMOYUKI HIRAI, KAZUO ENDO, MASATAKA HIRABAYASHI and TORU NAGANUMA

Anticancer Research December 2020, 40 (12) 7141-7145; DOI: https://doi.org/10.21873/anticanres.14744
You have access
Characterization of a Novel Barbituric Acid and Two Thiobarbituric Acid Compounds for Lung Cancer Treatment
SANG Y. LEE, BECKY SLAGLE-WEBB, ARUN K. SHARMA and JAMES R. CONNOR

Anticancer Research November 2020, 40 (11) 6039-6049; DOI: https://doi.org/10.21873/anticanres.14625

Main menu

User menu

Search

lung cancer

Pages